Sfoglia per Rivista  ONCOTARGET

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 1 a 20 di 28
Titolo Data di pubblicazione Autore(i) File
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience 1-gen-2017 Vici, P; Pizzuti, L; Michelotti, A; Sperduti, I; Natoli, C; Mentuccia, L; Di Lauro, L; Sergi, D; Marchetti, P; Santini, D; Magnolfi, E; Iezzi, L; Moscetti, L; Fabbri, A; Cassano, A; Grassadonia, A; Omarini, C; Piacentini, F; Botticelli, A; Bertolini, I; Scinto, Af; Zampa, G; Mauri, M; D'Onofrio, L; Sini, V; Barba, M; Maugeri-Sacca, M; Rossi, E; Landucci, E; Tomao, S; Alberti, Am; Giotta, F; Ficorella, C; Adamo, V; Russo, A; Lorusso, V; Cannita, K; Barni, S; Laudadio, L; Greco, F; Garrone, O; Della Giulia, M; Marolla, P; Sanguineti, G; Di Cocco, B; Ciliberto, G; De Maria, R; Gamucci, T
Antiangiogenic agents after first line and sorafenib plus chemoembolization: a systematic review 1-gen-2017 Gardini, Ac; Santini, D; Aprile, G; Silvestris, N; Felli, E; Foschi, Fg; Ercolani, G; Marisi, G; Valgiusti, M; Passardi, A; Puzzoni, M; Silletta, M; Brunetti, O; Cardellino, Gg; Frassineti, Gl; Scartozzi, M
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 1-gen-2015 Iuliani, Michele; Pantano, Francesco; Buttigliero, Consuelo; Fioramonti, Marco; Bertaglia, Valentina; Vincenzi, B; Zoccoli, Alice; Ribelli, Giulia; Tucci, Marcello; Vignani, Francesca; Berruti, Alfredo; Scagliotti Giorgio, Vittorio; Tonini, Giuseppe; Santini, Daniele
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 1-gen-2017 Fioramonti, M; Santini, D; Iuliani, M; Ribelli, G; Manca, P; Papapietro, N; Spiezia, F; Vincenzi, B; Denaro, V; Russo, A; Tonini, G; Pantano, F
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 1-gen-2016 Fanale, D; Amodeo, V; Bazan, V; Insalaco, L; Incorvaia, L; Barraco, N; Castiglia, M; Rizzo, S; Santini, D; Giordano, A; Castorina, S; Russo, A
Change from lung adenocarcinoma to small cell lung cancer as a mechanism of resistance to afatinib 1-gen-2017 Manca, P.; Russano, M.; Pantano, F.; Tonini, G.; Santini, D.
A close relationship between HIF-1α expression and bone metastases in advanced NSCLC, a retrospective analysis 1-gen-2019 Pezzuto, A; Perrone, G; Orlando, N; Citarella, F; Ciccozzi, M; Scarlata, S; Tonini, G
Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation. 1-gen-2016 Wang, J1; Papanicolau-Sengos, A2; Chintala, S3; 4, ; Wei, L1; Liu, B1; Hu, Q1; Miles, Km2; Conroy, Jm; Glenn, St; Costantini, M; Magi-Galluzzi, C; Signoretti, S; Choueiri, T; Gallucci, M; Sentinelli, S; Fazio, V. M.; Poeta, Ml; Liu, S; Morrison, C; Pili, R.
Deregulation of dicer and mir-155 expression in liposarcoma 1-gen-2015 Vincenzi, B; Iuliani, M; Zoccoli, A; Pantano, F; Fioramonti, M; De Lisi, D; Frezza, Am; Rabitti, C; Perrone, G; Onetti Muda, A; Russo, A; Giordano, A; Santini, D; Dei Tos, Ap; Tonini, G.
Efficacy and safety of T-DM1 in the 'common-practice' of HER2+advanced breast cancer setting: a multicenter study 1-gen-2017 Fabi, A; De Laurentiis, M; Caruso, M; Valle, E; Moscetti, L; Santini, D; Cannita, K; Carbognin, L; Ciccarese, M; Rossello, R; Arpino, G; Leonardi, V; Montemurro, F; La Verde, N; Generali, D; Zambelli, A; Scandurra, G; Russillo, M; Paris, I; D'Ottavio, Am; Filippelli, G; Giampaglia, M; Stani, S; Fabbri, A; Alesini, D; Cianniello, D; Giannarelli, D; Cognetti, F
Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone 1-gen-2016 Fradet, A.; Bouchet, M.; Delliaux, C.; Gervais, M.; Kan, C.; Benetollo, C.; Pantano, F.; Vargas, G.; Bouazza, L.; Croset, M.; Bala, Y.; Leroy, X.; Rosol, T. J.; Rieusset, J.; Bellahcene, A.; Castronovo, V.; Aubin, J. E.; Clezardin, P.; Duterque-Coquillaud, M.; Bonnelye, E.
Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression. 1-gen-2018 Trombetta, D; Graziano, P; Scarpa, A; Sparaneo, A; Rossi, G; Rossi, A; Di Maio, M; Antonello, D; Mafficini, A; Fabrizio, Fp; Manzorra, Mc; Balsamo, T; Centra, F; Simbolo, M; Pantalone, A; Notarangelo, M; Parente, P; Lucia Dimitri, Mc; Bonfitto, A; Fiordelisi, F; Storlazzi, Ct; L'Abbate, A; Taurchini, M; Maiello, E; Fazio, V. M.; Muscarella, La.
Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis 1-gen-2016 Vincenzi, B; Nannini, M; Fumagalli, E; Bronte, G; Frezza, Am; De Lisi, D; Ceruso, Ms; Santini, D; Badalamenti, G; Pantaleo, Ma; Russo, A; Dei Tos, A; Casali, P; Tonini, G
Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib 1-gen-2016 Gardini, Ac; Scarpi, E; Faloppi, L; Scartozzi, M; Silvestris, N; Santini, D; de Stefano, G; Marisi, G; Negri, Fv; Foschi, Fg; Valgiusti, M; Ercolani, G; Frassineti, Gl
Immunotherapeutic approaches for hepatocellular carcinoma 1-gen-2017 Longo, V; Gnoni, A; Gardini, Ac; Pisconti, S; Licchetta, A; Scartozzi, M; Memeo, R; Palmieri, Vo; Aprile, G; Santini, D; Nardulli, P; Silvestris, N; Brunetti, O
Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma. 1-gen-2017 Fabrizio, Fp; Costantini, M; Copetti, M; la Torre, A; Sparaneo, A; Fontana, A; Poeta, L; Gallucci, M; Sentinelli, S; Graziano, P; Parente, P; Pompeo, V; De Salvo, L; Simone, G; Papalia, R; Picardo, F; Balsamo, T; Flammia, Gp; Trombetta, D; Pantalone, A; Kok, K; Paranita, F; Muscarella, La; Fazio, Vm.
Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2- negative breast cancer 1-gen-2017 Fernandez-Martinez, A; Pascual, T; Perrone, G; Morales, S; de la Haba, J; González-Rivera, M; Galván, P; Zalfa, F; Amato, M; Gonzalez, L; Prats, M; Rojo, F; Manso, L; Paré, L; Alonso, I; Albanell, J; Vivancos, A; González, A; Matito, J; González, S; Fernandez, P; Adamo, B; Muñoz, M; Viladot, M; Font, C; Aya, F; Vidal, M; Caballero, R; Carrasco, E; Altomare, V; Tonini, G; Prat, A; Martin, M
Multigene tests for breast cancer: the physician's perspective 1-gen-2021 Cognetti, Francesco; Biganzoli, Laura; De Placido, Sabino; Del Mastro, Lucia; Masetti, Riccardo; Naso, Giuseppe; Pruneri, Giancarlo; Santini, Donatella; Tondini, Carlo Alberto; Tinterri, Corrado; Tonini, Giuseppe; Barni, Sandro
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis 1-gen-2017 Santini, D; Ratta, R; Pantano, F; De Lisi, D; Maruzzo, M; Galli, L; Biasco, E; Farnesi, A; Buti, S; Sternberg, Cn; Cerbone, L; Di Lorenzo, G; Spoto, S; Sterpi, M; De Giorgi, U; Berardi, R; Torniai, M; Camerini, A; Massari, F; Procopio, G; Tonini, G
PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis 1-gen-2016 Passiglia, F; Bronte, G; Bazan, V; Natoli, C; Rizzo, S; Galvano, A; Listi, A; Cicero, G; Rolfo, C; Santini, D; Russo, A
Mostrati risultati da 1 a 20 di 28
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile